Financials Medtecs International Corporation Limited
Equities
546
BMG5958R1043
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.129 SGD | -0.77% | +0.78% | -30.65% |
Apr. 15 | Medtecs’ Attributable Loss Narrows in 2023 | MT |
Feb. 29 | Medtecs International Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 10.86 | 15.1 | 416 | 141.8 | 81.34 | 76.84 |
Enterprise Value (EV) 1 | 43.47 | 55.93 | 370.5 | 108.8 | 66.45 | 76.08 |
P/E ratio | 11.9 x | 13 x | 3.16 x | 8.18 x | -2.85 x | -3.65 x |
Yield | - | - | 6.64% | 2.31% | - | - |
Capitalization / Revenue | 0.16 x | 0.22 x | 1.04 x | 0.98 x | 1.45 x | 1.46 x |
EV / Revenue | 0.64 x | 0.81 x | 0.93 x | 0.76 x | 1.18 x | 1.45 x |
EV / EBITDA | 8.6 x | 10.5 x | 2.64 x | 5.53 x | -2.23 x | -3.66 x |
EV / FCF | -46.4 x | -10.7 x | 9.11 x | 15.9 x | -17.2 x | -8.43 x |
FCF Yield | -2.16% | -9.37% | 11% | 6.31% | -5.8% | -11.9% |
Price to Book | 0.17 x | 0.24 x | 2.15 x | 0.76 x | 0.54 x | 0.59 x |
Nbr of stocks (in thousands) | 549,411 | 549,411 | 549,411 | 546,411 | 544,911 | 544,911 |
Reference price 2 | 0.0198 | 0.0275 | 0.7572 | 0.2595 | 0.1493 | 0.1410 |
Announcement Date | 4/3/19 | 4/15/20 | 4/13/21 | 4/15/22 | 6/15/23 | 4/14/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 68.3 | 68.98 | 400.3 | 144.2 | 56.24 | 52.64 |
EBITDA 1 | 5.053 | 5.327 | 140.2 | 19.69 | -29.78 | -20.76 |
EBIT 1 | 2.624 | 3.035 | 136.2 | 16.01 | -33.07 | -24.99 |
Operating Margin | 3.84% | 4.4% | 34.02% | 11.11% | -58.8% | -47.47% |
Earnings before Tax (EBT) 1 | 1.186 | 1.517 | 135.1 | 16.92 | -30.65 | -22.52 |
Net income 1 | 0.914 | 1.162 | 131.7 | 17.34 | -28.6 | -21.07 |
Net margin | 1.34% | 1.68% | 32.9% | 12.03% | -50.84% | -40.02% |
EPS 2 | 0.001659 | 0.002109 | 0.2397 | 0.0317 | -0.0524 | -0.0387 |
Free Cash Flow 1 | -0.9371 | -5.238 | 40.69 | 6.862 | -3.856 | -9.03 |
FCF margin | -1.37% | -7.59% | 10.16% | 4.76% | -6.86% | -17.15% |
FCF Conversion (EBITDA) | - | - | 29.03% | 34.85% | - | - |
FCF Conversion (Net income) | - | - | 30.89% | 39.57% | - | - |
Dividend per Share | - | - | 0.0503 | 0.006000 | - | - |
Announcement Date | 4/3/19 | 4/15/20 | 4/13/21 | 4/15/22 | 6/15/23 | 4/14/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 32.6 | 40.8 | - | - | - | - |
Net Cash position 1 | - | - | 45.5 | 32.9 | 14.9 | 0.76 |
Leverage (Debt/EBITDA) | 6.453 x | 7.665 x | - | - | - | - |
Free Cash Flow 1 | -0.94 | -5.24 | 40.7 | 6.86 | -3.86 | -9.03 |
ROE (net income / shareholders' equity) | 1.45% | 1.82% | 102% | 8.64% | -17.2% | -15.9% |
ROA (Net income/ Total Assets) | 1.47% | 1.65% | 47% | 4.34% | -10.4% | -8.96% |
Assets 1 | 61.98 | 70.29 | 280.3 | 399.7 | 275.1 | 235.2 |
Book Value Per Share 2 | 0.1100 | 0.1200 | 0.3500 | 0.3400 | 0.2700 | 0.2400 |
Cash Flow per Share 2 | 0.0100 | 0.0100 | 0.1500 | 0.0900 | 0.0300 | 0.0400 |
Capex 1 | 5.31 | 4.57 | 8.4 | 16.4 | 19.8 | 4.89 |
Capex / Sales | 7.77% | 6.63% | 2.1% | 11.36% | 35.17% | 9.29% |
Announcement Date | 4/3/19 | 4/15/20 | 4/13/21 | 4/15/22 | 6/15/23 | 4/14/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.65% | 51.58M | |
+11.84% | 27.79B | |
-32.98% | 2.98B | |
-15.97% | 2.52B | |
+11.90% | 2.34B | |
-1.11% | 1.91B | |
-13.37% | 1.83B | |
-7.78% | 1.39B | |
-0.38% | 1.27B | |
+4.01% | 1.13B |
- Stock Market
- Equities
- 546 Stock
- Financials Medtecs International Corporation Limited